Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. (2002). Swiss Medical Weekly, 132(2930), 414-414. https://doi.org/10.4414/smw.2002.10031